Physician profile
Janae Preece
NPI 1922233683
$1,144.39
in general payments reported to CMS, 2019-2025
9 companies · $506 in 2025
The $506 reported for 2025 was more than what 82% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2021: $137 · 2022: $16.66 · 2023: $134 · 2024: $22.16 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $241.39 | 2019-2021 | |
| Coloplast Corp | $152.26 | 2019-2022 | |
| Avita Medical Americas, LLC | $149.07 | 2025 | Cohealyx, Permeaderm, Recell |
| Photocure INC | $141.26 | 2025 | Cysview |
| Palette Life Sciences, INC. | $133.66 | 2023 | |
| Teleflex LLC | $111.43 | 2025 | Deflux Metal Needle |
| Ambu INC. | $104.00 | 2025 | |
| Boston Scientific Corporation | $89.16 | 2019 | |
| Novo Nordisk INC | $22.16 | 2024 | Rivfloza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janae Preece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.